Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial pyruvate carrier 1 (MPC1) is a protein that forms part of the mitochondrial pyruvate carrier complex. This complex is located in the inner mitochondrial membrane and facilitates the transport of pyruvate from the cytosol into the mitochondria. This process is essential for linking glycolysis to oxidative metabolism via the tricarboxylic acid (TCA) cycle. MPC1 is a therapeutic target for metabolic diseases and cancer.
Modulation of pyruvate transport into mitochondria, impacting glycolysis and oxidative phosphorylation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Pyruvate Carrier 1 (MPC1).